Recent Finacing
Recent Raise
R3 Vascular develops ultra-thin, bioresorbable polylactic acid vascular scaffolds coated with sirolimus, combining stent-like mechanical support and drug elution for below-the-knee peripheral artery disease.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at R3 Vascular.